Raydiant Oximetry, a women’s health company, raised $5 million in Series A2 funding, per Fortune’s Term Sheet. Avestria Ventures led the round and was joined by investors including KOFA Healthcare, V-Capital, Band of Angels, FemHealth Ventures, RHIA Ventures, and SteelSky Ventures.
Related Posts
XRHealth Raises $10M in Funding for Healthcare Metaverse
The round was backed by HTC, Bridges Israel impact investment fund, AARP, and crowdfunding on StartEngine.com and existing investors.
March 1, 2022
Brightside Health Raises $50M in Series B
ACME Capital and Mousse Partners led the round.
March 30, 2022
Amulet Capital Partners Recapitalizes Lighthouse
Lighthouse is a network of outpatient substance abuse and mental health treatment facilities.
March 31, 2022
Linden Invests in RQM+
Chicago-based healthcare private equity firm, announced today a majority investment in RQM+, a prior portfolio company of DFW Capital Partners, alongside the company’s founders and management team.
August 17, 2021